NCT00099853View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin

Vildagliptin 50 mg tablets

DRUG

pioglitazone

pioglitazone 45 mg qd

DRUG

Placebo

Vildagliptin matching placebo

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY